BioDrugs

5.8(top 5%)

impact factor

1.5K(top 20%)

papers

33.0K(top 10%)

citations

76(top 10%)

h-index

6.0(top 5%)

impact factor

1.6K

all documents

35.1K

doc citations

120(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The Impact of PEGylation on Biological Therapies	BioDrugs	2008	791
2	Adeno-Associated Virus (AAV) as a Vector for Gene Therapy	BioDrugs	2017	773
3	The Therapeutic Potential of Nanobodies	BioDrugs	2020	435
4	Oral Delivery of Peptide Drugs	BioDrugs	2005	385
5	Glycosylation of Therapeutic Proteins	BioDrugs	2010	371
6	Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders	BioDrugs	2001	360
7	Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters	BioDrugs	2015	320
8	The Application of Recombinant Human Collagen in Tissue Engineering	BioDrugs	2004	298
9	Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review	BioDrugs	2017	241
10	Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities	BioDrugs	2018	237
11	Cationic Antimicrobial Peptides	BioDrugs	2003	226
12	Epitope Mapping	BioDrugs	2007	217
13	Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases	BioDrugs	2019	195
14	Strategies to Extend Plasma Half-Lives of Recombinant Antibodies	BioDrugs	2009	192
15	Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies	BioDrugs	2010	173
16	Therapeutic Approaches in Multiple Sclerosis	BioDrugs	2002	167
17	Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab	BioDrugs	2013	161
18	Comparative Immunogenicity of TNF Inhibitors: Impact on Clinical Efficacy and Tolerability in the Management of Autoimmune Diseases. A Systematic Review and Meta-Analysis	BioDrugs	2015	158
19	Sunitinib	BioDrugs	2009	157
20	Interchangeability of Biosimilars: A European Perspective	BioDrugs	2017	153
21	Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma	BioDrugs	2007	152
22	Targeting Nerve Growth Factor in Pain	BioDrugs	2008	151
23	C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* Formulation	BioDrugs	2001	149
24	Trastuzumab in the Treatment of Breast Cancer	BioDrugs	2016	146
25	MicroRNA-Based Therapeutics for Cancer	BioDrugs	2009	140
26	Autologous Conditioned Serum in the Treatment??of Orthopedic Diseases	BioDrugs	2007	136
27	Locked Nucleic Acid Oligonucleotides	BioDrugs	2007	135
28	Designer Exosomes: A New Platform for Biotechnology Therapeutics	BioDrugs	2020	135
29	Quorum Sensing	BioDrugs	2003	133
30	Development of Pegylated Interferons for the Treatment of Chronic Hepatitis C	BioDrugs	2001	124
31	Bispecific Antibodies for Cancer Immunotherapy	BioDrugs	2010	124
32	Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor	BioDrugs	2009	122
33	Immunoglobulin Treatment for Primary Antibody Deficiencies	BioDrugs	2007	121
34	Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology	BioDrugs	2017	121
35	Strategies of Tumor Immune Evasion	BioDrugs	2005	120
36	Hyaluronic Acid in the Treatment of Knee Osteoarthritis	BioDrugs	2012	120
37	Bacteriophage Polysaccharide Depolymerases and Biomedical Applications	BioDrugs	2014	120
38	Selective Targeting of Cancer Stem Cells	BioDrugs	2007	119
39	Monomeric Fc Fusions	BioDrugs	2006	118
40	MicroRNAs in the Search for Understanding Human Diseases	BioDrugs	2007	114
41	Cationic Host Defence Peptides: Potential as Antiviral Therapeutics	BioDrugs	2013	114
42	Mission Possible: Advances in MYC Therapeutic Targeting in Cancer	BioDrugs	2019	113
43	Strategies for In Vivo Delivery of siRNAs	BioDrugs	2010	105
44	Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf	BioDrugs	2017	105
45	TNF?? Inhibitors in the Treatment of Psoriasis and Psoriatic Arthritis	BioDrugs	2005	101
46	Bilayered Bioengineered Skin Substitute (Apligraf??*)	BioDrugs	2002	100
47	Bacteriophages	BioDrugs	2002	100
48	Delivery of Growth Factors for Tissue Regeneration and Wound Healing	BioDrugs	2012	100
49	Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol	BioDrugs	2014	99
50	Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach	BioDrugs	2011	98

Scientometrics

Overviews

Citing Bodies

BioDrugs

Top Articles